PROCORT

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: PROCORT
Generic name: 1.85% HYDROCORTISONE ACETATE - 1.15% PRAMOXINE HCI CREAM
Manufacturer: Womens Choice Pharmaceuticals LLC
Product type: HUMAN PRESCRIPTION DRUG
SPL set ID: 9e899b72-a16e-4b55-93b5-ab5baec37d50
SPL ID: 33de5899-7f16-c8d3-e063-6394a90a27b3
Version: 6
Effective date: 2025-04-28
Source export date: 2026-09-28
Source partition: 9
Source file: https://download.open.fda.gov/drug/label/drug-label-0009-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/6784607726c827491ceaeab30d843632e0660ee8008c535197be5ed9e1e52201/drug-label-0009-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:04:44

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
brand name		PROCORT	openfda.brand_name
generic name		1.85% HYDROCORTISONE ACETATE - 1.15% PRAMOXINE HCI CREAM	openfda.generic_name
manufacturer name		Womens Choice Pharmaceuticals LLC	openfda.manufacturer_name
ndc	package	50967-357-60	openfda.package_ndc
ndc	product	50967-357	openfda.product_ndc
ndc11	package	50967035760	derived:openfda.package_ndc
rxcui		1114854	openfda.rxcui
rxcui		1115730	openfda.rxcui
spl id		33de5899-7f16-c8d3-e063-6394a90a27b3	id
spl set id		9e899b72-a16e-4b55-93b5-ab5baec37d50	set_id
unii		88AYB867L5	openfda.unii
unii		3X7931PO74	openfda.unii

Adverse reactions cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Adverse reactions sections page 1 of 1 · 1 matching rows.

adverse reactions

The following local adverse reactions are reported in frequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence; itching, burning, skin irritation.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.